Market Tracker

10/24 6:05pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.62
Data as of Oct 24
 +0.05 / +3.18%
Today’s Change
1.12
Today|||52-Week Range
2.71
-38.87%
Year-to-Date

Today’s Trading

Previous close1.57
Today’s open1.59
Day’s range1.55 - 1.70
Volume87,540
Average volume (3 months)152,079
Market cap$61.7M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+60.59%
Earnings growth (this year)+44.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-70.16%
P/E ratioNM
Price/Sales36.32
Price/Book5.54

Competitors

 Today’s
change
Today’s
% change
CBRXColumbia Laboratorie...-0.09-1.53%
PARNParnell Pharmaceutic...-0.13-2.77%
SCYXSCYNEXIS Inc+0.29+4.30%
KBIOKaloBios Pharmaceuti...-0.03-1.64%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.5M
Annual profit (last year)-$15.7M
Net profit margin-632.02%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Richard W. Pascoe
Chief Financial Officer, Secretary &
Senior VP
Steven Robert Martin
Corporate headquarters
San Diego, California

Forecasts